Diseases, Conditions, Syndromes

Study compares effectiveness of biologics in psoriasis treatment

(HealthDay)—For patients with psoriasis, ustekinumab has the highest effectiveness over five years of treatment and adalimumab and ustekinumab more often reach a 75 percent reduction in Psoriasis Area Severity Index (PASI) ...

Diseases, Conditions, Syndromes

Ixekizumab efficacious for psoriasis over 60 weeks

(HealthDay)—The benefits of ixekizumab in the treatment of psoriasis extend to 60 weeks, according to a study published online June 8 in the New England Journal of Medicine.

Diseases, Conditions, Syndromes

Secukinumab effective in moderate-to-severe psoriasis

(HealthDay)—For patients with moderate-to-severe plaque psoriasis, the fully human anti-interleukin-17A monoclonal antibody, secukinumab, is effective, according to research published online July 9 in the New England Journal ...

Diseases, Conditions, Syndromes

Etanercept seems beneficial in partial spinal cord injury

(HealthDay)—Treatment of rabbits with a partial spinal cord injury (SCI) with the intramuscularly-administered tumor necrosis factor-α (TNF-α) inhibitor etanercept is associated with improved clinical and electrophysiological ...

Diseases, Conditions, Syndromes

New drug can clear all psoriasis symptoms

A University of Manchester led trial of a new psoriasis drug has resulted in 40 percent of people showing a complete clearance of psoriatic plaques after 12 weeks of treatment and over 90 percent showing improvement.

Diseases, Conditions, Syndromes

Etanercept cuts sciatic pain from lumbar disc herniation

(HealthDay)—Compared with placebo, transforaminal injections of etanercept provide relief from leg and back pain in patients with symptomatic lumbar disc herniation (LDH), according to research published in the Nov. 1 issue ...

Arthritis & Rheumatism

Rheumatism drug also effective at half dose

The treatment of moderately active rheumatoid arthritis with the tumour necrosis factor inhibitor Etanercept achieves excellent success in more than 80 per cent of patients. With this method, the success can be maintained ...

page 2 from 3